APP13002

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameAPP13002
Drug Alias NameAPP13002APP-13002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMeibomian Gland DysfunctionBlepharitisKeratitis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFormosa Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesFormosa Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMeibomian Gland DysfunctionBlepharitisKeratitis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A